The distal axis of growth hormone (GH) in nutritional disorders: GH-binding protein, insulin-like growth factor-I (IGF-I), and IGF-I receptors in obesity and anorexia nervosa

Metabolism

Volumn 41, Issue 1, 1992, Pages 106-112

  Hochberg, Zeev ^a,b,c   Hertz, Pnina ^a,b,c   Colin, Varda ^a,b,c   Ish Shalom, Sophia ^a,b,c   Yeshurun, Daniel ^a,b,c   Youdim, Moussa B H ^a,b,c   Amit, Tamar ^a,b,c  

^a RAMBAM MEDICAL CENTER   (Israel)

^b TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

^c BNAI ZION MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE BINDING PROTEIN; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ADULT; AGE; ANOREXIA NERVOSA; ARTICLE; BODY MASS; CONTROLLED STUDY; ERYTHROCYTE; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUTRITION; OBESITY; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ANOREXIA NERVOSA; BODY MASS INDEX; CARRIER PROTEINS; FEMALE; GROWTH HORMONE; HUMAN; INSULIN-LIKE GROWTH FACTOR I; OBESITY; RECEPTORS, CELL SURFACE; RECEPTORS, SOMATOMEDIN; SOMATOMEDINS; SUPPORT, NON-U.S. GOV'T;

EID: 0026570421     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/0026-0495(92)90198-J     Document Type: Article

References (60)

1. Hypothalamic dysfunction in patients with anorexia nervosa
2. Hypothalamic-endocrine dysfunction in anorexia nervosa
3. Endocrine study of anorexia nervosa
4. Endocrine function in human obesity
5. Differential effects of feeding on the ultradian variation of the growth hormone (GH) response to GH-releasing hormone in normal subjects and patients with obesity and anorexia nervosa
6. Effect of cholinergic muscarinic receptor blockade on growth (GH) releasing hormone-(-1–44)-induced GH secretion in anorexia nervosa
7. The effect of the nutritional status and weight changes on hypothalamic function tests in anorexia nervosa
8. Effects of thyrotrophin-releasing hormone on plasma levels of TSH, FSH, LH and GH in anorexia nervosa
9. Growth hormone release following thyrotrophin-releasing hormone injection into patients with anorexia nervosa
10. Growth hormone and prolactin secretion after growth hormone releasing hormone administration in anorexia nervosa patients, normal controls and tamoxifen-pretreated volunteers
11. Somatomedin activity and growth hormone secretion
12. Growth hormone response in the thinned obese
13. Effect of arginine on serum levels of insulin and growth hormone in obese subjects
14. Plasma growth hormone response to l-dopa in obese subjects
15. Impaired growth hormone responses to growth hormone-releasing factor in obesity
16. Metabolic clearance rates of synthetic human growth hormone in lean and obese male rhesus monkeys
17. Growth hormone receptor and serum binding protein Purification cloning and expression
18. The interrelationship of growth hormone (GH), liver membrane GH receptor, serum GH-binding protein activity and insulin-like growth factor-I (IGF-I) in the male rat
19. Absence of serum growth hormone binding protein in patients with growth hormone receptor deficiency (Laron dwarfism)
20. Alterations of human growth hormone binding by rat liver membranes during hypo- and hyperthyroidism
21. The effect of human growth hormone (GH) therapy on GH binding protein in GH deficient children
22. Effects of hypo- or hyperthyroidism on growth hormone-binding protein
23. A new and convenient assay of growth hormone binding protein activity in human serum
24. Characterization of insulin-like growth factor I receptor on human erythrocytes
25. Estimation of somatomedin-C levels in normal and patients with pituitary disease by radioimmunoassay
26. 131I-labelled growth hormone of high specific activity
27. Characteristics of human erythrocyte insulin receptors
28. Regulation of somatomedin-C/insulin like growth factor I by nutrients
29. Serum insulin-like growth factors I and II concentrations and growth hormone and insulin responses to arginine infusion in children with protein-energy malnutrition before and after nutritional rehabilitation
30. Blood plasma levels of cortisol, insulin, growth hormone and somatomedin in children with marasmus, kwashiorkor and intermediate forms of protein energy malnutrition
31. Studies on growth hormone secretion in protein calorie malnutrition
32. The effect of fasting on liver receptors for prolactin and growth hormone
33. Divergent responses of serum insulin-like growth factor-I and liver growth hormone (GH) receptor to exogenous GH in protein-restricted rats
34. Relationship between increased binding and insulin-like effects of human growth hormone in adipocytes from young fa/fa rats
35. The response of obese subjects to continuous infusion of human pancreatic growth hormone releasing factor 1–44
36. Plasma triglycerides in genetically obese rats
37. Growth hormone and prolactin secretion in genetically obese Zucker rats
38. Adenohypophyseal response to hypophysiotropic hormones in male obese Zucker rats
39. In vitro and in vivo growth hormone responsiveness to growth hormone releasing factor in male and female Zucker rats
40. Interrelationship of growth hormone (GH), GH receptor, and GH-binding protein in human and rat
41. Somatotropin pulse frequency and basal concentrations are increased in acromegaly and are reduced by successful therapy
42. The effect of circulating growth hormone binding protein on metabolic clearance, distribution and degradation of human growth hormone
43. Evaluation of levels of serum growth hormone available for receptor binding
44. The growth hormone binding protein as a paradigm for the erythropoietin superfamily of receptors
45. Regulation of growth hormone (GH) bioactivity by a recombinant human GH-binding protein
46. Receptors for the insulin-like growth factors on human erythrocytes
47. Characteristics of human erythrocyte insulin-like growth factor I receptors
48. Insulin-like growth factor I receptors on erythrocytes in NIDDM
49. Monoclonal antibodies to receptors for insulin and somatomedin-C
50. The insulin resistance of acromegaly Evidence for two alterations in the insulin receptor on circulating monocytes
51. Fibroblasts from a patient with leprechaunism are resistant to insulin, epidermal growth factor, and somatomedin C
52. In vivo modulation of somatomedin receptor sites: Effects of growth hormone treatment of hypopituitary children
53. Plasma growth hormone, insulin and glucagon responses to arginine infusion in children and adolescents with idiopathic short stature, isolated growth hormone deficiency, panhypopituitarism and anorexia nervosa
54. Increased insulin binding to erythrocytes in anorexia nervosa. Restoration to normal with refeeding
55. Regulation by fasting of rat insulin-like growth factor I and its receptors. Effects on gene expression and binding
56. Characterization of a specific receptor for somatomedin C (SM-C) on cultured human lymphocytes; evidence that SM-C modulates homologous receptor concentrations
57. Characterization of the somatomedin-C/insulin-like growth factor I (SM-C/IGF-I) receptor on cultured human fibroblast monolayers: Regulation of receptor concentration by SM-C/IGF-I and insulin
58. Monoclonal antibody to the type I insulin-like growth factor (IGF-I) receptor blocks IGF-I receptor-mediated DNA synthesis: Clarification of the mitogenic mechanisms of IGF-I and insulin in human skin fibroblasts
59. Insulin-like growth factor/somatomedin C (IGF-I/SM-C) and glucocorticoids synergistically regulate mitosis in competent human fibroblasts